Zentiva in the UK
Zentiva (previously Winthrop Pharmaceuticals) develops and manufactures generic medicines providing the NHS with low cost alternatives to branded medicines. For over 25 years our uncompromising standards have delivered quality you can count on.
Zentiva, the European generics business for the Sanofi group, is the third largest and fastest growing generics company in Europe. With origins dating back to the 15th century, Zentiva is a valued generics partner.
Today, we are at the forefront of developing modern, high-quality and affordable medicines.
We currently operate in 32 markets, targeting a population of close to 800 million people. Zentiva holds leading positions in several pharmaceutical markets, such as the Czech Republic, Romania, Slovakia, and Turkey and is successfully expanding its business in other Western, Central and Eastern European markets.
Our success has been built on close and strong relations with key business partners, physicians, pharmacists and patients. Zentiva is committed to delivering high quality generic medicines and providing access to a range of educational and support programs.
Our broad product portfolio covers the main therapeutic areas. Our key product groups include anti-infectives and medicines for cardiovascular disease, pain, central nervous system disorders, female healthcare and gastrointestinal disease.
Zentiva has four key production plants in Central and Eastern Europe, enabling it to manufacture and distribute products across all its markets quickly and efficiently. We maintain the highest product quality and security standards across our manufacturing and supply lines. Our modern state-of-the-art facilities employ almost 3,000 people and produce an annual output of 440 million units, making Zentiva one of the largest producers of pharmaceuticals, by volume, in Europe.
Last update: 03/11/2011 02:09 AM